Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)
China · Delayed Price · Currency is CNY 29.53
-0.38 (-1.27%)
Apr 28, 2026, 3:00 PM CST
SHA:688321 Market Cap
SHA:688321 has a market cap or net worth of 13.08 billion as of April 28, 2026. Its market cap has increased by 73.19% in one year.
Market Cap
13.08B
Enterprise Value
13.98B
Revenue
910.06M
Ranking
n/a
PE Ratio
236.24
Stock Price
29.53
Market Cap Chart
Since August 12, 2019, SHA:688321's market cap has decreased from 39.08B to 13.08B, a decrease of -66.53%. That is a compound annual growth rate of -15.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 13.25B | 11.18% |
| Dec 31, 2025 | 11.92B | 57.27% |
| Dec 31, 2024 | 7.58B | -15.30% |
| Dec 29, 2023 | 8.95B | - |
| Dec 30, 2022 | 8.95B | -37.79% |
| Dec 31, 2021 | 14.38B | -5.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Hepalink Pharmaceutical Group | 14.47B |
| Beijing Aosaikang Pharmaceutical | 14.13B |
| Zhejiang Medicine | 13.80B |
| Zhejiang Hisun Pharmaceutical | 13.53B |
| Guobang Pharma | 13.39B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 13.02B |
| Shanghai Shyndec Pharmaceutical | 12.86B |
| Ningbo Menovo Pharmaceutical | 12.44B |